Summary:
Advarra launches Study Collaboration solution to streamline clinical trial processes.
Solution integrates Longboat technology for better real-time visibility and workflow automation.
80% of trials fail to enroll patients on time due to inefficiencies, which this solution aims to address.
The system enhances collaboration and compliance, ultimately speeding up the delivery of new treatments.
Streamlining Clinical Trials with Technology
Advarra, a leader in clinical research technology, has launched its Study Collaboration solution aimed at enhancing study startup processes. This innovative solution is designed to automate workflows, enhance real-time visibility, and encourage collaboration among research stakeholders.
Key Features of the Study Collaboration Solution
The solution integrates the Longboat technology acquired in 2020, which boasts over 225,000 users. It combines Advarra’s study startup delivery program and a single sign-on feature that simplifies access for research sites. This collaboration facilitates efficient management of crucial processes such as:
- Feasibility assessments
- Document exchange
- Site training
- Milestone tracking
- Enrollment planning
These improvements aim to reduce the time from site selection to recruitment, thus accelerating trial timelines.
Addressing Challenges in Clinical Trials
According to Ashley Davidson, VP at Advarra, study startup is often the most challenging part of clinical trials. Issues such as manual information exchange and disconnected systems can lead to delays, with 80% of trials failing to enroll patients on time. The new solution aims to tackle these inefficiencies to meet enrollment goals effectively.
Enhancing Collaboration and Compliance
The Study Collaboration solution provides a centralized view of activation and enrollment progress, allowing both sites and sponsors to streamline their workflows. This integration is expected to improve compliance and strengthen collaboration among various stakeholders, ultimately helping in accelerating the delivery of new treatments to patients.
Industry Endorsements
Industry leaders, such as Deb Tatton from Parexel and Nancy Cleverley from the Alliance for Multispecialty Research, have praised Advarra’s technology for its ability to simplify workflows and enhance training, leading to better engagement and efficiency at research sites.
For more information, visit Advarra's website.
Comments